Transcriptomic pathway analysis performed on the most potent serotonin modulator (triflupromazine) demonstrates selective down regulation of multiple cell cycle pathways and upregulation of tumor necrosis factor (TNF) signaling pathways in the most sensitive breast cancer cell type. Here, TNF is linked to breast cancer.